Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Done

Showing results (71-80 of 192) with videos related to

Pageof 20
Sort By:
Journal of Clinical Pathology|January 24, 2019
Breast specimen handling and reporting in the post-neoadjuvant setting: challenges and advancesMiralem Mrkonjic, Hal K Berman, Susan J Done, et al.
Breast Cancer Research and Treatment|March 23, 2001
P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancersS J Done, C R Arneson, H Ozçelik, et al.
Breast Cancer Research : BCR|July 6, 2014
Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populationsDong-Yu Wang, Susan J Done, David R Mc Cready, et al.
Journal of Intellectual Disability Research : JIDR|May 10, 2002
Difficulties in conducting a randomized controlled trial of health service interventions in intellectual disability: implications for evidence-based practiceP C Oliver, J Piachaud, J Done, et al.
Cancer Research|March 4, 1998
p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasiasS J Done, N C Arneson, H Ozçelik, et al.
Schizophrenia Research|June 15, 2007
Do overinclusion and distorted semantic category boundaries in schizophrenia arise from executive dysfunction?V A Lawrence, O Doughty, A Al-Mousawi, et al.
Nuclear Medicine and Biology|December 3, 2014
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of (111)In-BzDTPA-pertuzumabKaren Lam, Conrad Chan, Susan J Done, et al.
International Journal of Cancer|December 23, 2014
Identification of genomic signatures in circulating tumor cells from breast cancerNisha Kanwar, Pingzhao Hu, Philippe Bedard, et al.
British Journal of Cancer|April 15, 2026
TLR7 signature of tumour innervation reveals two distinct pathways of triple-negative breast cancer progressionDong-Yu Wang, Zhe Jiang, Yaacov Ben-David, et al.
Burns : Journal of the International Society for Burn Injuries|August 21, 2007
Body image, mood and quality of life in young burn survivorsS J Pope, W R Solomons, D J Done, et al.
Pageof 20

Showing results (71-80 of 192) with videos related to

Sort By:
Pageof 20
Journal of Clinical Pathology|January 24, 2019
Breast specimen handling and reporting in the post-neoadjuvant setting: challenges and advancesMiralem Mrkonjic, Hal K Berman, Susan J Done, et al.
Breast Cancer Research and Treatment|March 23, 2001
P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancersS J Done, C R Arneson, H Ozçelik, et al.
Breast Cancer Research : BCR|July 6, 2014
Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populationsDong-Yu Wang, Susan J Done, David R Mc Cready, et al.
Journal of Intellectual Disability Research : JIDR|May 10, 2002
Difficulties in conducting a randomized controlled trial of health service interventions in intellectual disability: implications for evidence-based practiceP C Oliver, J Piachaud, J Done, et al.
Cancer Research|March 4, 1998
p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasiasS J Done, N C Arneson, H Ozçelik, et al.
Schizophrenia Research|June 15, 2007
Do overinclusion and distorted semantic category boundaries in schizophrenia arise from executive dysfunction?V A Lawrence, O Doughty, A Al-Mousawi, et al.
Nuclear Medicine and Biology|December 3, 2014
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of (111)In-BzDTPA-pertuzumabKaren Lam, Conrad Chan, Susan J Done, et al.
International Journal of Cancer|December 23, 2014
Identification of genomic signatures in circulating tumor cells from breast cancerNisha Kanwar, Pingzhao Hu, Philippe Bedard, et al.
British Journal of Cancer|April 15, 2026
TLR7 signature of tumour innervation reveals two distinct pathways of triple-negative breast cancer progressionDong-Yu Wang, Zhe Jiang, Yaacov Ben-David, et al.
Burns : Journal of the International Society for Burn Injuries|August 21, 2007
Body image, mood and quality of life in young burn survivorsS J Pope, W R Solomons, D J Done, et al.
Pageof 20